There’s Been a Shift in Who’s Funding Alzheimer’s Research
THURSDAY, May 27, 2021 (HealthDay News) — The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer’s disease research, two new studies show. The findings are from an analysis of national data by Jeffrey Cummings, a research professor at the University of Nevada, Las VegasContinue Reading














